Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Progesterone versus Duphaston versus placebo for prevention of preterm birth
IRCT20180303038922N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of dydrogesterone and progesterone in Preterm labor (PTL) (3 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Uterine contractions and Gestational age at delivery. Started Apr 2018; status: completed.
02
Drugs
dydrogesteroneprogesterone
03
Conditions
Preterm labor (PTL)
Beyond the preview
Go deeper on IRCT20180303038922N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180303038922N1.